trial · primary record
APL-4098
Acute Myeloid Leukemia Refractory
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 100 |
| Primary completion | 2027-08 |
| Primary endpoint | Incidence of Treatment Emergent Adverse Events [Safety] |
| Registry ID | NCT06372717 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:42:59.766Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06372717
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.